Summary
Over 250 branded drugs in the U.S. will see price increases starting Jan. 1, 2025, with most hikes below 10% and a median increase of 4.5%.
Key companies like Pfizer, Bristol Myers Squibb, and Sanofi are raising prices on treatments for COVID-19, cancer, and vaccines, citing R&D costs and inflation.
Some prices, such as Merck’s diabetes drugs, will be reduced.
Critics highlight that U.S. drug prices remain the highest globally, while manufacturers face pressure to moderate year-over-year price hikes.
Slight tangent: a drug I’m on for a nervous system condition used to cost me $400 a month copay when I lived in the states. Now it’s €0.37 here in Portugal. Yup. 37 cents.
I guess they don’t have inflation in Portugal.